Overview
Tirzepatide Overview
Tirzepatide is a synthetic 39-amino-acid peptide modeled on the native GIP sequence. It carries two alpha-aminoisobutyric acid (Aib) residues at positions 2 and 13, a C-terminal amide, and a C20 fatty diacid attached to lysine 20 through a gamma-glutamic acid and two OEG spacer units.
What sets it apart is dual receptor activity. One molecule activates both the GIP receptor and the GLP-1 receptor, which makes it a useful tool for studying how the two incretin pathways interact. In receptor-expressing cell lines, it shows a distinct signaling profile at the GLP-1 receptor, favoring cAMP generation over β-arrestin recruitment. Its fatty diacid side chain is designed for reversible albumin binding, a property examined in in vitro protein binding studies.
Each lot is made by solid-phase peptide synthesis, third-party tested, and supplied with a Certificate of Analysis.
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(γGlu-OEG-OEG-C20 diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
|---|---|
| Sequence length | 39 amino acids |
| Also known as | LY3298176 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.5 g/mol |
| CAS number | 2023788-19-2 |
| PubChem CID | 156588324 |
| Form | Lyophilized powder |
| Purity | >99% by HPLC, per COA |
| Storage | -20°C, sealed and protected from light and moisture |
Certificate of Analysis
| Date | Lot | Certificate |
|---|---|---|
| Tirzepatide - 10mg11/3/2026 | 2611024075 | View COA |